Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Ambarella
AMBA
$3.6B
| $10.6M | 0.02% |
237,000
+108,550
| +85% | +$4.49M |
|
|
APEX
1102
DELISTED
Apex Global Brands Inc. Common Stock
APEX
| $10.6M | 0.02% |
19,843
-1,264
| -6% | -$626K |
|
1103
SK Telecom
SKM
$15B
| $10.5M | 0.02% |
316,975
+248,091
| +360% | +$8.03M |
|
|
CMBT
1104
CMB.TECH NV
CMBT
$5B
| $10.5M | 0.02% |
+1,028,100
| New | +$11.1M |
|
|
ATML
1105
DELISTED
ATMEL CORP
ATML
| $10.5M | 0.02% |
+1,294,800
| New | +$10.5M |
|
|
HTO
1106
H2O America
HTO
$2.65B
| $10.5M | 0.02% |
288,900
+167,000
| +137% | +$5.62M |
|
1107
PTC
PTC
$16.4B
| $10.5M | 0.02% |
316,500
-221,300
| -41% | -$6.83M |
|
|
NSU
1108
DELISTED
Nevsun Resources Ltd.
NSU
| $10.5M | 0.02% |
3,231,191
+498,391
| +18% | +$1.49M |
|
1109
H.B. Fuller
FUL
$3.28B
| $10.4M | 0.02% |
246,100
+87,500
| +55% | +$3.27M |
|
|
B
1110
DELISTED
Barnes Group Inc.
B
| $10.4M | 0.02% |
298,200
+289,500
| +3,328% | +$9.59M |
|
1111
RPM International
RPM
$14.3B
| $10.4M | 0.02% |
220,600
-20,700
| -9% | -$857K |
|
1112
Nexstar Media Group
NXST
$5.81B
| $10.4M | 0.02% |
235,200
+220,509
| +1,501% | +$9.98M |
|
1113
SITE Centers
SITC
$157M
| $10.4M | 0.02% |
454,174
+279,319
| +160% | +$6.01M |
|
|
EPAY
1114
DELISTED
Bottomline Technologies Inc
EPAY
| $10.4M | 0.02% |
341,100
-41,842
| -11% | -$1.2M |
|
1115
RPC Inc
RES
$1.43B
| $10.4M | 0.02% |
731,619
+660,200
| +924% | +$8.37M |
|
|
JBTM
1116
JBT Marel
JBTM
$6.18B
| $10.3M | 0.02% |
183,300
-16,732
| -8% | -$814K |
|
|
BFS
1117
Saul Centers
BFS
$874M
| $10.3M | 0.02% |
194,700
+11,426
| +6% | +$574K |
|
1118
SEI Investments
SEIC
$12.8B
| $10.3M | 0.02% |
239,326
-160,874
| -40% | -$6.6M |
|
1119
Scorpio Tankers
STNG
$3.99B
| $10.3M | 0.02% |
176,459
+21,737
| +14% | +$1.29M |
|
|
LDL
1120
DELISTED
Lydall, Inc.
LDL
| $10.3M | 0.02% |
315,900
+6,900
| +2% | +$202K |
|
|
CARB
1121
DELISTED
Carbonite Inc
CARB
| $10.3M | 0.02% |
1,288,900
+90,400
| +8% | +$738K |
|
|
SCLN
1122
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $10.3M | 0.02% |
932,300
+349,220
| +60% | +$3.11M |
|
|
FRGI
1123
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $10.3M | 0.02% |
312,766
+119,600
| +62% | +$4.21M |
|
|
SMI
1124
DELISTED
Semiconductor Manufacturing Intl
SMI
| $10.2M | 0.02% |
2,301,100
+121,010
| +6% | +$532K |
|
|
AHRT
1125
AH Realty Trust
AHRT
$509M
| $10.2M | 0.02% |
909,368
+227,111
| +33% | +$2.42M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.